Where is ValueGene located?

ValueGene is headquartered in San Diego, United States.

How many employees does ValueGene have?

As of Jul 31, 2026, the latest employee count at ValueGene is 4.

Where does ValueGene rank among its competitors?

ValueGene ranks 565th amongst 588 active competitors, of which 47 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Sebia, which secured an undisclosed amount in May, 2026.

Who are the top competitors of ValueGene?

ValueGene's top competitors include Enzo, BGI and Sino Biological. Among them, Sebia secured the most recent funding round in May, 2026.

ValueGene - 2026 Company Profile & Competitors

Company Details

Specializing in primer oligonucleotides for virus PCR and viral detection. The company focuses on providing primer oligonucleotides essential for Virus PCR and viral detection. This indicates a business model centered around biotechnology and life sciences, specifically catering to research, diagnostics, and potentially pharmaceutical applications. The company likely serves B2B clients in the healthcare, research, and diagnostic sectors. Their offerings are critical for molecular biology research, disease detection, and development of diagnostic tools. The business model involves manufacturing and supplying specialized reagents for scientific and medical communities.

Website: www.valuegene.com/
Social

Key Metrics

Founded Year

2005

Location

San Diego, United States

Stage

Acqui-Hired

Ranked

565^th among 588 active competitors

Employee Count

4 as on Jul 31, 2026

Similar Companies

BGI & 440 more

View ValueGene's full profile

ValueGene has not raised any funding rounds yet.

ValueGene's employee count trend

ValueGene has 4 employees as of Jul 26. Here is ValueGene's employee count trend over the years:

Uncover ValueGene's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of ValueGene include Enzo, BGI and Sino Biological. Here is the list of Top 10 competitors of ValueGene, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Enzo 1976, Farmingdale (United States), Acquired	Life science products and services for research, drug discovery, and manufacturing	$7M	-	65/100
2nd	BGI 1999, Shenzhen (China), Public	Provider of services in genome sequencing	-	Sequoia Capital China, Yunfeng Capital & 15 others	64/100
3rd	Sino Biological 2007, Beijing (China), Series A	Provider of reagents,and kits for clinical research	$29.4M	Qiming Venture Partners, CTS Capital & 1 others	63/100
4th	Devyser 2004, Stockholm (Sweden), Public	Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders	$15.5M	Swedbank Robur, Fjarde AP-fonden & 1 others	61/100
5th	Miltenyi Biotec 1989, Bergisch Gladbach (Germany), Funding Raised	Develops tools and products for research and clinical application	-	Europa, HHS	58/100
6th	Sebia 1967, Evry Courcouronnes (France), Acquired	Developer of electrophoresis-based in vitro diagnostics products	-	Warburg Pincus, HarbourVest Partners & 5 others	56/100
7th	BioIVT 1981, Westbury (United States), Acquired	Provider of in vitro diagnostic products and assay services	-	WILsquare Capital, Thompson Street Capital Partners ... & 4 others	56/100
8th	Teknova 1996, Hollister (United States), Public	Provider of molecular biology research reagents and kits	-	Cambrian Growth Partners, Telegraph Hill Partners ... & 1 others	56/100
9th	GenScript 2002, Piscataway (United States), Public	Provider of reagents and instruments for life sciences research	$15M	Kleiner Perkins, Vermögensclub & 1 others	55/100
10th	Firefly BioWorks 2009, Cambridge (United States), Acquired	Develops platform to allow multiplexed assays on standard laboratory instrumentation	$3.77M	PBM Capital, Breton Capital Ventures & 3 others	54/100
565th	ValueGene 2005, San Diego (United States), Acqui-Hired	Specializing in primer oligonucleotides for virus PCR and viral detection	-	-	17/100